Digoxin
Form: Intravenous (IV) Injection
Strength: 250 mcg/mL
Reference Brands: Lanoxin(US & EU)
Category: Critical Care
Digoxin is a cardiac glycoside used in the treatment of heart failure and atrial fibrillation. It enhances myocardial contractility while controlling ventricular rate by inhibiting the sodium-potassium ATPase pump. Available in oral tablets (62.5, 125, and 250 mcg), oral solution (50 mcg/mL), and IV injection (250 mcg/mL), Digoxin is widely used in both acute and chronic cardiac care. In the US, Lanoxin and Pfizer’s generic injections are common, while EU brands include Lanoxin, Digoxin Hameln, and Meda. Hospitals, cardiology centers, and clinics procure Digoxin regularly through pharma B2B platforms and hospital group purchasing organizations.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Glucagon
Strength: 1 mg lyophilized powder for reconstitution (IM/SC/IV)
Form: Intramuscular (IM), Subcutaneous (SC), and Intravenous (IV) injection
Reference Brands: Glucagen®, Gvoke®,Baqsimi®(US); Glucagen® Hypokit(EU)
View Details Get Enquiry
Insulin (IV)
Strength: 100 units/mL (U-100) in 10 mL vials
Form: Intravenous (IV) solution
Reference Brands: Humulin® R, Novolin® R(US); Actrapid®, Humulin® R, Insuman® Rapid(EU)
View Details Get Enquiry
Flumazenil
Strength: 0.1 mg/mL in 5 mL or 10 mL vials
Form: Intravenous (IV) injection
Reference Brands: Romazicon®(US), Anexate®(EU)
View Details Get Enquiry
Naloxone
Strength: 0.4 mg/mL in 1 mL/10 mL vials, 1 mg/mL in 2 mL prefilled syringes
Form: Intravenous (IV) injection/IM/SQ
Reference Brands: Narcan® (US); Narcan® (EU)
View Details Get Enquiry